What's happening
This bill restricts the off-label use of antipsychotic drugs with black box warnings on elderly dementia patients and establishes penalties for violations.
Why it matters
Significantly limits the use of powerful antipsychotic drugs—especially those with serious FDA warnings—on elderly dementia patients. , reducing the risk of harmful side effects and the controversial practice of using these drugs as "chemical restraints" for behavior control rather than for genuine medical need.
Requires that any emergency use of these drugs must be justified, documented, and administered only by dementia specialists or specially trained professionals. , ensuring tighter oversight and greater accountability in patient care.
Mandates immediate notification and documentation for both the patient (or their legal representative) and relevant family members whenever such drugs are used. , increasing transparency and allowing families to be more involved in the medical care decisions of vulnerable relatives.
Establishes that violations can be considered professional misconduct for healthcare providers. , creating clear legal consequences that may deter inappropriate prescribing and encourage adherence to safer, evidence-based practices in elder care settings.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Limit Antipsychotics for Dementia
Plain English, a few words. Used as the page title.
Sponsors
Senator · Senate District 14
No co-sponsors yet.
History
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Limit Antipsychotics for Dementia
In Assembly Committee · Health · Sponsor Alicia Hyndman
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
6462
2021-2022 Regular Sessions
IN SENATE
April 29, 2021
Introduced by Sen. COMRIE -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the public health law, in relation to limiting the off label use of antipsychotic drugs with black box warnings on elderly patients with dementia; and to amend the education law, in relation to professional medical misconduct
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The public health law is amended by adding a new section 280-d to read as follows:
§ 280-d. Use of antipsychotic drugs on elderly patients with dementia. 1. As used in this section:
(a) "off label" means a medical practice in which a physician prescribes a drug for a different medical purpose than the one for which such drug is approved for;
(b) "black box warning" means a warning issued by the federal Food and Drug Administration and placed on the package insert of a prescription drug that may be fatal or cause server side effects;
(c) "chemical restraint" means when an antipsychotic drug that provides no medical benefit to a patient with dementia and is used to sedate such patient, control such patient's behavior or restrict such patient's movement;
(d) "antipsychotic drug" means any typical or atypical antipsychotic drug that is intended to be used on patients with mental illness that require a black box warning and shall include but not be limited to the following:
(i) Typical antipsychotic drugs: haloperidol, loxapine, thioridazine, molindone, thiothixene, fluphenazine, trifluoperazine, chlorpromazine, perphenazine, or promozide; or
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD11120-01-1
S. 6462 2
(ii) Atypical antipsychotic drugs: aripiprazole, lumapeterone, clozaril, iloperidone, ziprasidone, paliperidone, lurasidone, brexipiprazole, risperidone, asenapine, quetiapine, cariprazine, or olanzapine; and
(e) "patient" means an elderly individual with dementia who is:
(i) a resident of a residential health care facility as defined in article twenty-eight of this chapter or an adult care facility certified under section four hundred sixty-one-b of the social services law; or
(ii) in the care of a hospital as defined in article twenty-eight of this chapter, a facility as defined in article twenty of this chapter or any other health care facility who care for individuals with dementia.
2. No antipsychotic drug that contains a black box warning shall be used for an off label purpose on a patient known to have dementia or to chemically restrain a patient known to have dementia. An order for an antipsychotic drug may only be issued in an emergency situation and by a health care professional who specializes in dementia or is specifically trained in the treatment of dementia patients if such a patient is agitated and where it is reasonably necessary to protect the life, health or safety of the patient or another person. Where an order is made under this subdivision, the health care professional shall immediately record the use of the antipsychotic drug, the reason for the use, and the dosage, in the patient's medical record; and shall promptly notify the patient or the patient's lawful representative who would have had the authority to consent that such drug with a black box warning was used and any family member required to be notified under this section and record such notifications in the patient's medical record.
3. This section does not increase the lawful scope of practice of any health care professional and does not diminish or impair any requirement for or regulation of consent to health care treatment. A health care professional who fails to comply with the provisions of this section may be found guilty of professional misconduct pursuant to article one hundred thirty-one-a of the education law.
4. The commissioner may make rules or regulations to implement the provisions of this section.
§ 2. Section 6530 of the education law is amended by adding a new subdivision 51 to read as follows:
51. Failing to comply with the provisions of section two hundred eighty-d of the public health law.
§ 3. This act shall take effect on the thirtieth day after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to limiting the off label use of antipsychotic drugs with black box warnings on elderly patients with dementia; and to amend the education law, in relation to professional medical misconduct
Purpose
Physicians and healthcare providers regularly prescribe antipsychotic drugs with black box warning to elderly patients with dementia, result- ing in patient illness and death. Antipsychotic drugs are not approved for use in dementia care-they treat schizophrenia, and bipolar disorder, among other appropriate illnesses. Such drugs are recommended for use as a last resort in cases where a patient poses risk to self or others.
Summary of provisions
Section 1 defines "off label", "black box warning", "chemical restraint", antipsychotic drug", and other terms.
Section 2 amends the education law by adding a new subdivision.
Section 3 states the act shall take effect on the thirtieth day after becoming law.
Existing law
None.
Justification
There are concerns of widespread misuse of antipsychotic drugs on people with dementia. Antipsychotic drugs are not approved for use in dementia care. The correct and intended use is for patients with mental disorders such as schizophrenia and bi-polar disorders. When antipsychotics are used on dementia patients there are serious side effects sometimes resulting in death. Antipsychotics use in dementia patents increases the risk of strokes, arrhythmia, QT prolongation, cardia arrest, pneumonia and even death.
There is a black box warning on all typical and atypical antipsychotic drugs. Nevertheless, many doctors ignore these warnings and go off label prescribing these drugs with serious and deadly consequences. These drugs are often administered by understaffed and poorly trained health care workers as a chemical restraint. In other words, the but for the convenience of health care workers who find it easier to care for docile sedated patients. Using antipsychotic drugs this way as a chemical restraint, is unethical and should never be allowed because it is unnec- essary and puts the patient at risk of dangerous side effects including mortality.
Legislative history
None.
Fiscal implications
To be determined.
Local fiscal implications
To be determined
Effective date
The act shall take effect on the thirtieth day after it shall have become law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.